Search

Gudrun Vogtentanz Phones & Addresses

  • Sunnyvale, CA
  • Mountain View, CA

Resumes

Resumes

Gudrun Vogtentanz Photo 1

Gudrun Vogtentanz

View page

Publications

Us Patents

Compositions Comprising Bowman-Birk Protease Inhibitors And Variants Thereof

View page
US Patent:
7696173, Apr 13, 2010
Filed:
Jul 14, 2008
Appl. No.:
12/172921
Inventors:
Katherine Collier - Los Altos CA, US
Grant Ganshaw - Tracy CA, US
Hans De Nobel - Almere, NL
Scott D. Power - San Bruno CA, US
Anita Van Kimmenade - San Bruno CA, US
Marc Kolkman - Oegstgeest, NL
Jeffrey Miller - Santa Cruz CA, US
Brian Schmidt - Halfmoon Bay CA, US
Gudrun Vogtentanz - Santa Clara CA, US
David Estell - San Mateo CA, US
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
A61K 38/16
US Classification:
514 12
Abstract:
The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.

Personal Care Compositions Comprising Modified Variant Bowman Birk Protease Inhibitors

View page
US Patent:
7772181, Aug 10, 2010
Filed:
Oct 15, 2008
Appl. No.:
12/252032
Inventors:
Neelam S. Amin - Palo Alto CA, US
Katherine D. Collier - Los Altos CA, US
Melodie Estabrook - Mountain View CA, US
David A. Estell - San Francisco CA, US
Bryan P. Fox - Pacifica CA, US
Scott D. Power - San Bruno CA, US
Brian F. Schmidt - Half Moon Bay CA, US
Gudrun Vogtentanz - Santa Clara CA, US
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
A61K 38/00
A61K 8/00
US Classification:
514 2, 424 701, 424 59, 424 63, 424 69
Abstract:
The present invention relates to compositions that comprise modified variant Bowman Birk Protease Inhibitor proteins (BBPIs). The modified variant BBPIs comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses the compositions comprising the modified variant BBPIs, and the methods for making and using the compositions in personal care.

Modified Variant Bowman Birk Protease Inhibitors

View page
US Patent:
7803902, Sep 28, 2010
Filed:
Oct 15, 2008
Appl. No.:
12/252062
Inventors:
Neelam S. Amin - Palo Alto CA, US
Katherine D. Collier - Los Altos CA, US
Melodie Estabrook - Mountain View CA, US
David A. Estell - San Francisco CA, US
Bryan P. Fox - Pacifica CA, US
Scott D. Power - San Bruno CA, US
Brian F. Schmidt - Half Moon Bay CA, US
Gudrun Vogtentanz - Santa Clara CA, US
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
C07K 14/00
US Classification:
530324
Abstract:
The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

Bacterial Expression Of Protease Inhibitors And Variants Thereof

View page
US Patent:
20050202535, Sep 15, 2005
Filed:
Nov 8, 2004
Appl. No.:
10/984514
Inventors:
Katherine Collier - Los Altos CA, US
Grant Ganshaw - Tracy CA, US
Hans De Nobel - Almere, NL
Scott Power - San Bruno CA, US
Anita Van Kimmenade - San Bruno CA, US
Marc Kolkman - Oegstgeest, NL
Jeffrey Miller - Santa Cruz CA, US
Brian Schmidt - Halfmoon Bay CA, US
Gudrun Vogtentanz - Santa Clara CA, US
David Estell - San Mateo CA, US
International Classification:
C12N009/99
C07H021/04
C12N015/74
C12N001/21
US Classification:
435069200, 435184000, 435252300, 435471000, 536023200
Abstract:
The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.

Cellulase Variants With Improved Expression, Activity And Stability, And Use Thereof

View page
US Patent:
20120135500, May 31, 2012
Filed:
Jun 3, 2010
Appl. No.:
13/321928
Inventors:
Wolfgang Aehle - Zwingenberg, DE
Richard R. Bott - Burlingame CA, US
Benjamin Bower - Newark CA, US
Jonathan Caspi - sunnyvale CA, US
David A. Estell - San Francisco CA, US
Frits Goedegebuur - vlaardingen, NL
Ronaldus W.J. Hommes - Haarlem, NL
Thijs Kaper - Half Moon Bay CA, US
Bradley Kelemen - Menlo Park CA, US
Slavko Kralj - Oegstgeest, NL
Johan Van Lieshout - Utrecht, NL
Igor Nikolaev - Noordwijk, NL
Sander Van Stigt Thans - Zevenbergen, NL
Louise Wallace - Palo Alto CA, US
Gudrun Vogtentanz - Sunnyvale CA, US
Mats Sandgren - Uppsala, SE
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
C12N 9/42
US Classification:
435209
Abstract:
The present disclosure relates to cellulase variants. In particular the present disclosure relates to cellulase variants having improved expression, activity and/or stability. Also described are nucleic acids encoding the cellulase variants, compositions comprising the cellulase variants, and methods of use thereof.

Protease Variants And Uses Thereof

View page
US Patent:
20200332229, Oct 22, 2020
Filed:
May 31, 2017
Appl. No.:
16/305259
Inventors:
- Palo Alto CA, US
Michael STONER - Palo Alto CA, US
Adam GARSKE - Palo Alto CA, US
Joshua Roy BASLER - Palo Alto CA, US
Katherine AUGUSTYN - San Francisco CA, US
Priyanka CHANDRASEKARAN - Brisbane CA, US
Miles Christopher SCOTCHER - San Ramon CA, US
Lilia Maria BABE - Emerald Hills CA, US
Richard R. BOTT - Kirkland WA, US
David A. ESTELL - San Mateo CA, US
Gudrun VOGTENTANZ - Sunnyvale CA, US
Sina PRICELIUS - Leiden, NL
Jian YAO - Sunnyvale CA, US
Assignee:
Danisco US Inc. - Palo Alto CA
International Classification:
C11D 3/386
C12N 9/54
C12N 15/52
Abstract:
Disclosed herein is one or more subtilisin variant, nucleic acid encoding same, and compositions and methods related to the production and use thereof, including one or more subtilisin variant that has improved stability and/or soil removal compared to one or more reference subtilisin.
Gudrun Vogtentanz from Sunnyvale, CA, age ~53 Get Report